Ascendis reports positive 52-week trial data for achondroplasia treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. JMKE
2. REF
3. BABA
4. NVDA
5. TSLA
6. XPEV
7. GGR
8. BA
9. SPY
10. IBM

Go back to Ascendis reports positive 52-week trial data for achondroplasia treatment
Asianada, Inc. (NASDAQ: ASND) Delayed: 253.29 --0 (-0%)
Previous Close $253.29    52 Week High $21.79 
Open $253.29    52 Week Low $11.92 
Day High $253.29    P/E N/A 
Day Low $253.29    EPS $-0.07 
Volume 1,079